𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Early in vivo changes of the transcriptome in Philadelphia chromosome-positive CD34+ cells from patients with chronic myelogenous leukaemia following imatinib therapy

✍ Scribed by Bruennert, D; Czibere, A; Bruns, I; Kronenwett, R; Gattermann, N; Haas, R; Neumann, F


Book ID
109886708
Publisher
Nature Publishing Group
Year
2008
Tongue
English
Weight
139 KB
Volume
23
Category
Article
ISSN
0887-6924

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Results of triple therapy with interfero
✍ Susan O'Brien; Francis Giles; Moshe Talpaz; Jorge Cortes; Mary Beth Rios; Jianqi 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

## Abstract ## BACKGROUND Before the discovery of imatinib mesylate, a Bcr‐Abl selective tyrosine kinase inhibitor, three agents, interferon‐alpha (IFN‐α), cytarabine (ara‐C), and homoharringtonine (HHT), had demonstrated activity against Philadelphia chromosome (Ph)‐positive chronic myelogenous l

Intermediate dose of imatinib in combina